Parental Acceptance of HPV Vaccine in Peru: A Decision Framework

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Bartolini, Rosario M ^a   Winkler, Jennifer L ^b   Penny, Mary E ^a   LaMontagne, D Scott ^b,c  

^a INSTITUTO DE INVESTIGACIÓN NUTRICIONAL   (Peru)

^b PATH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CONCEPTUAL FRAMEWORK; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG SAFETY; FAMILY INTERACTION; FEAR; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; INFORMED CONSENT; MASS MEDIUM; MEDICAL DECISION MAKING; MOTIVATION; NONLINEAR SYSTEM; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PATIENT ATTITUDE; PERU; PREVENTIVE MEDICINE; QUALITATIVE RESEARCH; RISK BENEFIT ANALYSIS; TEACHER; TRUST; UTERINE CERVIX CANCER;

ADULT; CHILD; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MODELS, PSYCHOLOGICAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENT-CHILD RELATIONS; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PERU; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84868092713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048017     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Globocan 2008 V1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer. Available: http://globocan.iarc.fr/.
2. Parkin DM, Bray F, (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24: S11-S25.
3. Pan American Health Organization (2007) Peru. Health in the Americas. Washington, DC: Pan American Health Organization. 577-595.
4. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L, (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24: S1-S10.
5. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL, (2011) Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 53Suppl 1: S12-21.
6. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, et al. (2007) Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369: 2161-2170.
7. The FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356: 1915-1927.
8. Schiffman M, Wacholder S, (2012) Success of HPV vaccination is now a matter of coverage. Lancet Oncol 13: 10-12.
9. Munira SL, Fritzen SA, (2007) What influences government adoption of vaccines in developing countries? A policy process analysis. Soc Sci Med 65: 1751-1764.
10. Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T, (1999) Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries. Vaccine 18: 736-742.
11. Agosti JM, Goldie SJ, (2007) Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med 356: 1908-1910.
12. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B, (2006) Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 24: S201-S209.
13. Penny M, Bartolini R, Mosqueira NR, LaMontagne DS, Mendoza MA, et al. (2011) Strategies to vaccinate against cancer of the cervix: Feasibility of a school-based HPV vaccination program in Peru. Vaccine 5022-5030.
14. Dempsey AF, Zimet GD, (2008) Human papillomavirus vaccine and adolescents. Curr Opin Obstet Gynecol 20: 447-454.
15. Flick U (2006) An Introduction to Qualitative Research, 3rd ed. London: SAGE.
16. Fazekas KI, Brewer NT, Smith JS, (2008) HPV vaccine acceptability in a rural southern area. J Womens Health (Larchmt) 17: 539-548.
17. Dahlstrom LA, Tran TN, Lundholm C, Young C, Sundstrom K, et al. (2010) Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden. Int J Cancer 126: 500-507.
18. Sam IC, Wong LP, Rampal S, Leong YH, Pang CF, et al. (2009) Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolesc Health 44: 610-612.
19. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, et al. (2011) Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 89: 821-830B.
20. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, et al. (2008) Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 336: 1056-1058.
21. Cooper Robbins S, Bernard D, McCaffery K, Brotherton JM, Skinner SR, (2010) "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychol 29: 618-625.
22. Scarinci IC, Garces-Palacio IC, Partridge EE, (2007) An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health (Larchmt) 16: 1224-1233.
23. Podolsky R, Cremer M, Atrio J, Hochman T, Arslan AA, (2009) HPV vaccine acceptability by Latino parents: a comparison of U.S. and Salvadoran populations. J Pediatr Adolesc Gynecol 22: 205-215.
24. Lee FH, Paz-Soldan VA, Carcamo C, Garcia PJ, (2010) Knowledge and attitudes of adult Peruvian women vis-a-vis human papillomavirus (HPV), cervical cancer, and the HPV vaccine. J Low Genit Tract Dis 14: 113-117.
25. Brewer NT, Fazekas KI, (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45: 107-114.
26. Ferris DG, Cromwell L, Waller JL, Horn L, (2010) Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children. J Low Genit Tract Dis 14: 179-184.
27. Katahoire A, Arube-Wani J, Murokara D, Mugisha E, LaMontagne DS (2012) Acceptability of HPV vaccine among young adolescent girls in Uganda: young people's perspective count. Int J Child Adolesc Health: In press.
28. Brabin L, Roberts SA, Stretch R, Baxter D, Elton P, et al. (2009) A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer 101: 1502-1504.
29. Robbins SC, Bernard D, McCaffery K, Skinner SR, (2010) 'It's a logistical nightmare!' Recommendations for optimising human papillomavirus school-based vaccination experience. Sex Health 7: 271-278.